EyePoint Pharmaceuticals
EYPT
#5261
Rank
A$2.10 B
Marketcap
A$25.42
Share price
-1.75%
Change (1 day)
162.18%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -A$0.34 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are A$42.34 Million. In 2024 the company made an earning of -A$0.21 Billion a decrease over its 2023 earnings that were of -A$98.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.34 Billion66.17%
2024 -A$0.21 Billion104.29%
2023 -A$98.12 Million-29.88%
2022 -A$0.14 Billion87.2%
2021 -A$74.75 Million38.58%
2020 -A$53.94 Million-24.56%
2019 -A$71.5 Million
2017 -A$32.61 Million22.59%
2016 -A$26.6 Million-8.02%
2015 -A$28.92 Million-296.09%
2014 A$14.74 M-174.02%
2013 -A$19.93 Million37.42%
2012 -A$14.5 Million-56.29%
2011 -A$33.17 Million-1062.38%
2010 A$3.44 M-250.43%
2009 -A$2.3 Million-89.5%
2008 -A$21.83 Million
2005 -A$13.46 Million56.99%
2004 -A$8.58 Million73.7%
2003 -A$4.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.06 Million-98.99% Bahamas
NRC Health
NRC
A$38.94 M-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA